Skip to content
healthcare.dev
Get a free key

VPRIV

NDC 54092-701, velaglucerase alfa, injection, powder, lyophilized, for solution, from Takeda Pharmaceuticals America, Inc..

Product NDC
54092-701
Status
Listed
Labeler
Takeda Pharmaceuticals America, Inc.
Dosage form
INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION
Route
INTRAVENOUS
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
BLA
Application
BLA022575
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/54092-701 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • VELAGLUCERASE ALFA2.5 mg/mL

Pharmacologic classes

Hydrolytic Lysosomal Glucocerebroside-specific Enzyme [EPC]

Package NDCNDC-11Package
54092-701-04540920701041 VIAL, GLASS in 1 BOX (54092-701-04) / 4 mL in 1 VIAL, GLASS

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/ca02f7a4-ae4f-43c1-a06a-259fe4fcf9cf

  • Medicare Part B payment limits (ASP)

    GET /v1/drugs/asp?ndc=54092-701

Use it

Look up 54092-701 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/54092-701 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 54092-701. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Get a free keyNDC docsConnect the MCP server

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.